All News

Dr. Lorna Breen Health Care Provider Protection Act aims to help physicians receive mental health assistance without jeopardizing their licenses.

It was a busy week for the Contemporary OB/GYN® team.

Cancer misinformation may be more prevalent among residents in rural vs urban areas, study finds.

Risk factors for the dual burden of severe maternal morbidity and preterm birth differ significantly by insurance type across sociodemographic and perinatal considerations in the state of California, according to a study in the Maternal and Children Health Journal.

Patients with acute vulvovaginal candidiasis (VVC) greatly benefited from oral ibrexafungerp (Brexafemme, Scynexis), according to results of a global phase 3 randomized, double-blind, placebo-controlled superiority study published in the international journal of obstetrics and gynecology, BJOG.

Many new therapies have been developed over the past decade to treat disorders that are often present at birth and early treatment can lead to better outcomes. However, the screenings for newborns have been slow to adapt.

Patients with endometriosis are nearly four times as likely to develop rheumatoid arthritis (RA) than those without endometriosis, according to a study in the Journal of Women’s Health.

The NVX-CoV2373 vaccine was evaluated in adolescents aged 12 to 17 years.

Postmenopausal vaginal symptom severity is not significantly linked to vaginal microbiota or mucosal inflammatory markers, according to a small study in the American Journal of Gynecology & Obstetrics.

Robert Califf was approved in a 50-46 vote by the senate.

This is the first time in 18 years that financial challenges were not the top issue.

Prior authorizations are an obvious obstacle for physicians, but it also negatively impacts employers.

A look at what's coming to Contemporary OB/GYN this week

The safety of the Pfizer/BioNTech COVID-19 vaccine in pregnant women, for both mother and baby, has been dependent on observation during the rollout. A large population trial provides further support for the vaccine’s safety.

In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.

A 4-year follow-up of a randomized control study comparing uterine artery embolization (UAE) to myomectomy for treating women with uterine fibroids has concluded that myomectomy achieves greater improvement in quality of life.

A study in the Journal of Minimally Invasive Gynecology concluded that, in select pateints with deep infiltrating endometriosis (DIE) whom do not require bowel or ureteral resection, bladder function significantly improves after surgery, both during filling and in voiding urodynamic phases.

Uterine fibroids (UF) with heavy menstrual bleeding (HMB) pose a significant economic burden—mostly due to surgical and procedural costs and treatment, according to a claims analysis in the Journal of Women’s Health.

A look back on this week's news.

Scynexis released data from its pivotal Phase 3 CANDLE study of oral ibrexafungerp (BREXAFEMME) for the prevention of recurrent vulvovaginal candidiasis.

Because the treatment options for imminent extreme premature labor center largely on patient preference, decision aids (DA) can help facilitate the patient-provider discussion and guide the shared decision-making process.

“Over 70% of women are estimated to develop uterine fibroids by age 50,” said senior author Irene Aninye, PhD, chief science officer for the Society for Women’s Health Research (SWHR) in Washington, D.C. “Fibroids are a complex condition that can range from being asymptomatic to having deleterious effects on a woman’s health and quality of life.”

A different perspective on designing transfersomal nanocarriers of nystatin to treat vulvovaginal candidiasis (VVC) is reflected in a prospective in-vitro study in the journal Colloids and Surfaces B: Biointerfaces.

CooperSurgical, Inc, a global provider of health products for women, babies, and families, announced Monday plans to acquire the Reproductive Health division of Cook Medical, a manufacturer for minimally invasive medical devices in the fertility, obstetrics, and gynecology markets.

Take steps to ensure a positive first and lasting impression.

Get the Facts. Get Vaccinated.

Contraceptive effectiveness is determined by several factors, including drug or device efficacy, individual fecundability, coital frequency, and user adherence and continuation.

Experts evaluate 3 clinical scenarios and determine the appropriate course of action.